Differentiated Therapeutics raises $5 million in seed funding

Differentiated Therapeutics is a differentiated therapeutics provider focused on computational prediction and optimization of targeted protein degraders (TPDs) and the discovery and development of translational medicines to treat patients with life-changing diseases, designed and developed for patients with unmet medical needs Disease-modifying TPD therapy. Differentiated Therapeutics (dx/tx) recently announced the completion of $5 million in seed financing, led by Curie.Bio.

This article is reproduced from: https://www.itjuzi.com/investevent/13438515
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.